Tycho Bismeijer

Amsterdam, NH, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Poor Outcome in Postpartum Breast Cancer Patients Is Associated with Distinct Molecular and Immunologic Features.

Poor Outcome in Postpartum Breast Cancer Patients Is Associated with Distinct Molecular and Immunologic Features.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: November 23, 2022

Comprehensive multiplexed immune profiling of the ductal carcinoma in situ immune microenvironment regarding subsequent ipsilateral invasive breast cancer risk.

Comprehensive multiplexed immune profiling of the ductal carcinoma in situ immune microenvironment regarding subsequent ipsilateral invasive breast cancer risk.

Journal: British journal of cancer

Published: November 23, 2021

Contralateral parenchymal enhancement on MRI is associated with tumor proteasome pathway gene expression and overall survival of early ER+/HER2-breast cancer patients.

Contralateral parenchymal enhancement on MRI is associated with tumor proteasome pathway gene expression and overall survival of early ER+/HER2-breast cancer patients.

Journal: Breast (Edinburgh, Scotland)

Published: June 23, 2021

Breast adipocyte size associates with ipsilateral invasive breast cancer risk after ductal carcinoma in situ.

Breast adipocyte size associates with ipsilateral invasive breast cancer risk after ductal carcinoma in situ.

Journal: NPJ breast cancer

Published: August 06, 2020

Radiogenomic Analysis of Breast Cancer by Linking MRI Phenotypes with Tumor Gene Expression.

Radiogenomic Analysis of Breast Cancer by Linking MRI Phenotypes with Tumor Gene Expression.

Journal: Radiology

Published: May 27, 2020

Are contralateral parenchymal enhancement on dynamic contrast-enhanced MRI and genomic ER-pathway activity in ER-positive/HER2-negative breast cancer related?

Are contralateral parenchymal enhancement on dynamic contrast-enhanced MRI and genomic ER-pathway activity in ER-positive/HER2-negative breast cancer related?

Journal: European journal of radiology

Published: July 01, 2019

Genomic data integration by WON-PARAFAC identifies interpretable factors for predicting drug-sensitivity in vivo.

Genomic data integration by WON-PARAFAC identifies interpretable factors for predicting drug-sensitivity in vivo.

Journal: Nature communications

Published: July 26, 2018

Molecular characterization of breast and lung tumors by integration of multiple data types with functional sparse-factor analysis.

Molecular characterization of breast and lung tumors by integration of multiple data types with functional sparse-factor analysis.

Journal: PLoS computational biology

Published: November 16, 2017

The BRCA1ness signature is associated significantly with response to PARP inhibitor treatment versus control in the I-SPY 2 randomized neoadjuvant setting.

The BRCA1ness signature is associated significantly with response to PARP inhibitor treatment versus control in the I-SPY 2 randomized neoadjuvant setting.

Journal: Breast cancer research : BCR

Published: March 27, 2017

Complementary Value of Contralateral Parenchymal Enhancement on DCE-MRI to Prognostic Models and Molecular Assays in High-risk ER+/HER2- Breast Cancer.

Complementary Value of Contralateral Parenchymal Enhancement on DCE-MRI to Prognostic Models and Molecular Assays in High-risk ER+/HER2- Breast Cancer.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: January 20, 2017

Integration of genomic, transcriptomic and proteomic data identifies two biologically distinct subtypes of invasive lobular breast cancer.

Integration of genomic, transcriptomic and proteomic data identifies two biologically distinct subtypes of invasive lobular breast cancer.

Journal: Scientific reports

Published: July 23, 2015

A multilevel pan-cancer map links gene mutations to cancer hallmarks.

A multilevel pan-cancer map links gene mutations to cancer hallmarks.

Journal: Chinese journal of cancer

Published: May 27, 2015

Showing 1-12 of 13

Last Updated: 09/26/2026